• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7312
Medical Device Problem Code High Readings (2459)
Health Effect - Clinical Codes Hypoglycemia (1912); Dizziness (2194)
Date of Event 03/24/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Event or Problem Description
The customer reported that she obtained a blood glucose reading of 180 mg/dl at 7:19 a.M.With the contour next gen meter.The customer stated that she was experiencing symptoms of hypoglycemia which she described as feeling dizzy.The customer went to the hospital where a blood glucose test was performed and a reading of 40 mg/dl was obtained.The customer was given intravenous medication at 11:00 a.M.No further event details were provided.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
The customer returned the suspected contour next gen meter and contour next test strips from lot # 2fpeg06a for evaluation.An in-house testing was performed with the returned meter and returned test strips using blood sample, which gave a satisfactory performance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key16761531
Report Number1810909-2023-00073
Device Sequence Number6105964
Product Code NBW
UDI-Device Identifier10301937312219
UDI-Public10301937312219
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K193407
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 03/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date06/30/2024
Device Model Number7312
Device Catalogue Number7312
Device Lot Number2FPEG06A
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/25/2023
Supplement Date Received by Manufacturer07/26/2023
Initial Report FDA Received Date04/18/2023
Supplement Report FDA Received Date08/07/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/01/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
Patient SexFemale
-
-